Akebia Therapeutics, Inc. Announces Proposed Public Offering Of Common Stock

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA) today announced that it intends to offer to sell $60 million of shares of its common stock in an underwritten public offering. As part of this offering, Akebia Therapeutics, Inc. intends to grant the underwriters a 30-day option to purchase up to an additional $9 million of shares of its common stock.

Help employers find you! Check out all the jobs and post your resume.

Back to news